Ipilimumab + VemurafenibUnknown
7.3 Concurrent Ipilimumab Increases in transaminases and bilirubin occurred in a majority of patients who received concurrent ipilimumab and ZELBORAF [see Warnings and Precautions Section 5.6 ].
Source: FDA drug label - vemurafenib